MKS InstrumentsMKSI
About: MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.
Employees: 10,200
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
1,125% more call options, than puts
Call options by funds: $197M | Put options by funds: $16M
36% more repeat investments, than reductions
Existing positions increased: 169 | Existing positions reduced: 124
33% more funds holding in top 10
Funds holding in top 10: 3 [Q3] → 4 (+1) [Q4]
20% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 54
4.97% more ownership
Funds ownership: 99.64% [Q3] → 104.61% (+4.97%) [Q4]
1% more funds holding
Funds holding: 405 [Q3] → 411 (+6) [Q4]
1% more capital invested
Capital invested by funds: $7.28B [Q3] → $7.35B (+$70.1M) [Q4]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Benchmark Mark Miller 17% 1-year accuracy 6 / 35 met price target | 92%upside $135 | Buy Maintained | 14 Feb 2025 |
Morgan Stanley Joseph Moore 42% 1-year accuracy 26 / 62 met price target | 110%upside $147 | Overweight Maintained | 14 Feb 2025 |
Needham James Ricchiuti 18% 1-year accuracy 21 / 119 met price target | 107%upside $145 | Buy Maintained | 14 Feb 2025 |
Goldman Sachs Toshiya Hari 43% 1-year accuracy 39 / 90 met price target | 84%upside $129 | Neutral Maintained | 14 Feb 2025 |
Cantor Fitzgerald Matthew Prisco 12% 1-year accuracy 3 / 26 met price target | 100%upside $140 | Overweight Reiterated | 13 Feb 2025 |
Financial journalist opinion









